Which are the distinctive advantage of our PK/PD services?
We develop pharmacokinetic and pharmacodynamic population models that associate dose-concentration with the concentration-effect relationship of drugs characterizing the drug behavior.
Our modeling and simulation solutions provide input that can lead to fewer failed compounds, fewer study failures, and a smaller number of studies needed for registration.
- Optimization of drug action in individual patients
- Reduction of cost and time spent on research and development